Tenax Therapeutics (TENX) Non Operating Investment Income (2014 - 2021)
Tenax Therapeutics (TENX) reported Non Operating Investment Income of $2.0 for Q4 2021, down 99.79% on a YoY basis from $973.0 in Q4 2020, and up 100.72% sequentially from -$276.0 in Q3 2021.
Tenax Therapeutics (TENX) Non Operating Investment Income (2014 - 2021) Analysis & Trends
Tenax Therapeutics (TENX) has 8 years of Non Operating Investment Income data on file, last reported at $2.0 in Q4 2021.
- For the quarter ending Q4 2021, Non Operating Investment Income fell 99.79% year-over-year to $2.0; the trailing twelve-month figure through Sep 2022 stood at $2.0 (down 99.78% YoY), and the FY2021 full-year result was -$70.0, down 113.26% from the prior year.
- Non Operating Investment Income improved to $2.0 in Q4 2021, from -$276.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $10857.0 in Q1 2018 to a low of -$10556.0 in Q2 2018.
- A 5-year average of -$936.05 and a median of -$202.0 in 2021 frame the typical range for Non Operating Investment Income.
- Across the five-year window, Non Operating Investment Income soared 265.93% in 2018 and plunged 583.12% in 2020, its largest moves.
- Tracing TENX's Non Operating Investment Income over 5 years: stood at $10444.0 in 2017, then slumped by 200.51% to -$10497.0 in 2018, then jumped by 108.2% to $861.0 in 2019, then grew by 13.01% to $973.0 in 2020, then slumped by 99.79% to $2.0 in 2021.
- Business Quant data shows TENX's Non Operating Investment Income at $2.0 in Q4 2021, -$276.0 in Q3 2021, and -$128.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.00 |
| Dec 31, 2021 | 2.00 |
| Sep 30, 2021 | -276.00 |
| Sep 30, 2021 | -276.00 |
| Jun 30, 2021 | -128.00 |
| Jun 30, 2021 | -128.00 |
| Mar 31, 2021 | 332.00 |
| Mar 31, 2021 | 332.00 |
| Dec 31, 2020 | 973.00 |
| Dec 31, 2020 | 973.00 |
| Sep 30, 2020 | 1,171.00 |
| Sep 30, 2020 | 1,171.00 |
| Jun 30, 2020 | -3,238.00 |
| Jun 30, 2020 | -3,238.00 |
| Mar 31, 2020 | 1,622.00 |
| Mar 31, 2020 | 1,622.00 |
| Dec 31, 2019 | 861.00 |
| Dec 31, 2019 | 861.00 |
| Sep 30, 2019 | 960.00 |
| Sep 30, 2019 | 960.00 |